Aquis AQSE - Delayed Quote GBp
EDX Medical Group Plc (EDX.AQ)
10.11
-1.64
(-13.96%)
At close: 1:43:42 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Michael John Hudson | CEO & Director | -- | -- | 1958 |
| Sir Christopher Thomas Evans ARCS, B.Sc., DSc, FIB, FMEDSCI, FREng, FRSA, FRSC | Founder, Chief Scientific Officer & Director | -- | -- | 1957 |
| Dr. Liam Dower | Head of Quality, Regulatory Affairs & Compliance | -- | -- | -- |
| Dr. Keti Zeka | Head of R&D and Director of Laboratories | -- | -- | -- |
EDX Medical Group Plc
210-211 Milton Road
Cambridge, CB4 0WA
United Kingdom
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
EDX Medical Group Plc engages in developing a range of diagnostics testing solutions in the United Kingdom. It engages in the development of tests for diabetes, obesity, inflammatory disorders, and kidney and liver disorders. The company was formerly known as TECC Capital PLC and changed its name to EDX Medical Group Plc in November 2022. EDX Medical Group Plc was incorporated in 2021 and is based in Cambridge, the United Kingdom.
Corporate Governance
EDX Medical Group Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available